Lumenis Announces First Quarter 2015 Earnings Conference Call

YOKNEAM, Israel, April 28, 2015 (GLOBE NEWSWIRE) -- Lumenis Ltd. (Nasdaq: LMNS), the world's largest energy-based medical company for aesthetic, surgical and ophthalmology applications, today announced plans to release its first quarter of fiscal year 2015 financial results on Tuesday, May 12, 2015, after market close.

In conjunction with the release, management will host a conference call on Tuesday, May 12, 2015, at 5:00 p.m. (Eastern). To listen to the conference call on your telephone, please dial the following numbers approximately ten minutes prior to the start of the call: 888-299-7209 for callers based in the United States, 1-80-924-5906 for callers based in Israel and 719-457-2689 for callers based in all other countries. The reservation code for the call is 9681069. A live webcast of the conference call will also be available on the investor relations page of the company's website at http://investor.lumenis.com.

A telephone replay will be available for 14 days following the call. To listen to the replay, please dial 888-203-1112 for United States-based callers and 719-457-0820 for international callers. The reservation code is 9681069. A replay of the webcast will be available on the investor relations page of the company's website.

About Lumenis

Lumenis (Nasdaq: LMNS) is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods in each and every one of the verticals we operate in. Our drive for innovation stems from an uncompromising commitment to improving the health and well-being of our patients; addressing new and growing needs of aging populations; and in offering medical professionals cutting-edge solutions that fit seamlessly into the health-economics environment of the 21st century. The world over, we bring Energy to Healthcare.

For more information visit: www.lumenis.com

CONTACT: For Investor Inquiries:
         Mark Klausner or Michael Piccinino, CFA
         Westwicke Partners, LLC.
         443.213.0500
         [email protected]

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• REA Group to buy 35% stake in Ireland's Distilled for €248m
• Gates acquires Timken's belts business, adding Mexico facility